from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1591/-

LFCtreatmentdescriptionclass of inhibitor

-0.314

Amikacinug/mL Amikacintranslation

-1.044

Cap5-10ug/mL Capreomycintranslation

-1.007

Rox10-50 ug/mL Roxithromycintranslation

0.387

SM2-5 ug/mL Streptomycintranslation

-2.975

Tet5-10 ug/mL Tetracyclinetranslation

1.143

Rif0.2-5ug/mL Rifampicintranscription

0.090

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.431

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.435

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.441

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.266

Clofazimine10-13 ug/mL Clofaziminerespiration

0.410

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.427

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.659

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.115

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.001

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.013

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.083

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.645

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.178

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.057

KCN5-20 ug/mL Potassium cyaniderespiration

0.056

NaN30.2-2 mM Sodium aziderespiration

-0.530

Nigericin50 uM Nigericinrespiration

-0.685

TRC10-150 ug/mL Triclosanrespiration

-1.898

TRZ10-25 ug/mL Thioridazinerespiration

-1.030

Valinomycin0.5-10 uM Valinomycinrespiration

0.674

ZnSO42 mM ZnSO4respiration

-0.153

menadione6-10 ug/mL Menadionerespiration

-0.070

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.205

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.243

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.357

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.580

NRP_1Non-replicating persistence stage 1dosRassociated

0.381

Amp0.2mg/mL AmpicillincellWall

0.380

Cephalexin20-100 ug/mL CephalexincellWall

0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

0.627

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.416

EMB10-20 ug/mL EthambutolcellWall

0.154

Eta12-40 ug/mL EthionamidecellWall

0.568

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.159

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.374

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.465

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.069

BZA0.12 mg/mL BenzamidearomaticAmides

0.338

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.352

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.004

H2O24 mM hydrogen peroxideDNAdamaging

1.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.639

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.930

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.853

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.963

UVUV-irradiationDNAdamaging

-0.995

ARP41-4 ug/mL Antitubercular compound ARP4?

0.552

Antimycin12.5-50 ug/mL Antimycin A?

0.537

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.220

PA_110-50 ug/mL Antitubercular compound PA-1?

0.409

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.524

PA8240.2-2 ug/mL PA-824?

-0.313

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.787

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.274

Verapamil50 uM Verapamil?

-0.018

mercaptoethanol2 mM 2-Mercaptoethanol?

0.143

methoxatin10-20 ug/mL Methoxatin?